RNA, U6 small nuclear 610, pseudogene (RNU6-610P)

RNU6-610P is a human pseudogene derived from the U6 small nuclear RNA gene. U6 snRNA is normally a critical component of the spliceosome, which catalyzes the removal of introns from pre-mRNA during splicing[1][3]. However, RNU6-610P represents a defective, non-functional copy of the U6 snRNA gene lacking protein-coding ability, and by definition does not participate in the canonical functions associated with U6 snRNA. Pseudogenes like RNU6-610P can be transcribed and may, in rare cases, exert regulatory functions by acting as decoys for miRNAs or participating in chromatin remodeling, but no disease role, therapeutic value, or drug interaction is established for this specific pseudogene[2][4][5]. The "610" in its name specifies its locus or variant number in the human genome. Key insight: RNU6-610P is not a drug target; it is a transcriptionally inactive locus classified as a pseudogene. Its presence and potential regulatory effects are the subject of genomic and transcriptomic research, but it holds no current direct relevance for pharmacology, therapy, or biomarker development[2][4][5].

Other names

RNU6-610PU6-610 pseudogeneU6 small nuclear RNA pseudogene 610

None directly applicable (as above)